Publikationen in Zusammenarbeit mit Forschern von Hospital General Universitario de Valencia (136)

2024

  1. Paclitaxel alters melanogenesis and causes pigmentation in the skin of gynecological cancer patients

    Fundamental and Clinical Pharmacology, Vol. 38, Núm. 1, pp. 183-191

  2. Phosphodiesterase 4 is overexpressed in human keloids and its inhibition reduces fibroblast activation and skin fibrosis

    Chemico-Biological Interactions, Vol. 402

  3. Phosphodiesterase 4 is overexpressed in keloid epidermal scars and its inhibition reduces keratinocyte fibrotic alterations

    Molecular Medicine, Vol. 30, Núm. 1

  4. Pirfenidone and nintedanib attenuates pulmonary artery endothelial and smooth muscle cells transformations induced by IL-11

    European Journal of Pharmacology, Vol. 972

  5. Targeting IL-11 to reduce fibrocyte circulation and lung accumulation in animal models of pulmonary hypertension-associated lung fibrosis

    British Journal of Pharmacology, Vol. 181, Núm. 16, pp. 2991-3009

2023

  1. Damaging effects of UVA, blue light, and infrared radiation: in vitro assessment on a reconstructed full-thickness human skin

    Frontiers in Medicine, Vol. 10

  2. Evaluation of Delayed-Type Hypersensitivity to Antineoplastic Drugs—An Overview

    Cancers, Vol. 15, Núm. 4

  3. Influence of dose and exposition time in the effectiveness of N-Acetyl-L-cysteine treatment in A549 human epithelial cells

    Heliyon, Vol. 9, Núm. 5

  4. Mechanisms underlying corticosteroid resistance in patients with asthma: a review of current knowledge

    Expert Review of Respiratory Medicine, Vol. 17, Núm. 8, pp. 701-715

  5. Molecular and Clinical Predictors of Quality of Life in Chronic Rhinosinusitis with Nasal Polyps

    Journal of Clinical Medicine, Vol. 12, Núm. 4

  6. Obacunone Photoprotective Effects against Solar-Simulated Radiation–Induced Molecular Modifications in Primary Keratinocytes and Full-Thickness Human Skin

    International Journal of Molecular Sciences, Vol. 24, Núm. 14

  7. Targeting IL-11 system as a treatment of pulmonary arterial hypertension

    Pharmacological research, Vol. 197, pp. 106985

2022

  1. Cost-effectiveness analysis of the first‐line EGFR‐TKIs in patients with advanced EGFR-mutated non-small-cell lung cancer

    Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 22, Núm. 4, pp. 637-646

  2. Evaluation of Antineoplastic Delayed-Type Hypersensitivity Skin Reactions In Vitro

    Pharmaceuticals, Vol. 15, Núm. 9

  3. IL-11 system participates in pulmonary artery remodeling and hypertension in pulmonary fibrosis

    Respiratory Research, Vol. 23, Núm. 1

  4. Increased Expression of Galectin-3 in Skin Fibrosis: Evidence from In Vitro and In Vivo Studies

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

  5. N-acetylcysteine Reduces Inflammasome Activation Induced by SARS-CoV-2 Proteins In Vitro

    International Journal of Molecular Sciences, Vol. 23, Núm. 23

  6. Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients

    Cancers, Vol. 14, Núm. 5

  7. Paclitaxel-Induced Epidermal Alterations: An In Vitro Preclinical Assessment in Primary Keratinocytes and in a 3D Epidermis Model

    International Journal of Molecular Sciences, Vol. 23, Núm. 3

  8. Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis

    Frontiers in Pharmacology, Vol. 12